PCM
INSP icon

Prelude Capital Management’s Inspire Medical Systems INSP Stock Holding History

Prelude Capital Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,331
Closed -$223K – 1383
2026
Q1 		$223K Buy
+4,331
New +$303K 0.02% 857
2025
Q4 		– Sell
-5,735
Closed -$426K – 1418
2025
Q3 		$426K Buy
+5,735
New +$581K 0.03% 554
2025
Q2 		– Sell
-1,400
Closed -$223K – 1165
2025
Q1 		$223K Buy
+1,400
New +$253K 0.02% 872
2024
Q1 		– Sell
-1,310
Closed -$266K – 1421
2023
Q4 		$266K Buy
+1,310
New +$212K 0.02% 789
2018
Q3 		– Sell
-100
Closed -$4K – 1868
2018
Q2 		$4K Buy
+100
New +$3.23K ﹤0.01% 1568

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Prelude Capital Management's INSP Position: Q2 2026 in Review

Prelude Capital Management sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 4,331 shares — an estimated $223K sold.

Prelude Capital Management first reported a position in INSP in Q2 2018 and held it in 5 quarters. The position peaked at $426K in Q3 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Prelude Capital Management reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Prelude Capital Management sold 4,331 Inspire Medical Systems shares in Q2 2026, an estimated $223K.
  • Prelude Capital Management first reported a position in Inspire Medical Systems in Q2 2018 and held it in 5 quarters.
  • Prelude Capital Management's Inspire Medical Systems position peaked at $426K in Q3 2025.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.